There is now convincing evidence that various tissues express their ow
n tissue renin-angiotensin system, which may be regulated independentl
y of the systemic renin-angiotensin system. However, little informatio
n is available on the regulation of the tissue renin-angiotensin syste
m. We investigated the regulation of tissue angiotensinogen gene expre
ssion with respect to the development of hypertension. We measured bas
al and lipopolysaccharide-stimulated plasma angiotensinogen concentrat
ions by radioimmunoassay and examined the expression of tissue angiote
nsinogen by Northern blot analysis in spontaneously hypertensive rats
(SHR) and Wistar-Kyoto rats (WKY) at 4 and 13 weeks of age. Basal plas
ma angiotensinogen concentration in SHR was comparable to that in WKY
at 4 weeks of age and was significantly higher than that in WKY at 13
weeks of age. Lipopolysaccharide induced a significant increase in pla
sma angiotensinogen concentration in both WKY and SHR at 4 and 13 week
s of age. At 4 weeks of age, the basal levels of angiotensinogen mRNA
in the liver, fat, adrenal, and aorta were higher in WKY than in SHR.
At 13 weeks of age, the basal levels of angiotensinogen mRNA in the fa
t, adrenal, aorta, spleen, and kidney were higher in WKY than in SHR,
while that in the liver did not differ significantly between the two s
trains. At 4 weeks of age, pretreatment with lipopolysaccharide increa
sed the angiotensinogen mRNA levels in the liver, fat, adrenal, and ao
rta in both WKY and SHR. At 13 weeks of age, pretreatment with lipopol
ysaccharide increased the angiotensinogen mRNA levels in the liver, ao
rta, and adrenal; decreased those in the spleen; and had no effect in
the kidney in both WKY and SHR. Interestingly, lipopolysaccharide incr
eased the angiotensinogen mRNA level in fat only in SHR, with no effec
t in WKY, at 13 weeks of age. Lipopolysaccharide stimulated tumor necr
osis factor-alpha mRNA expression in fat of WKY and SHR, and the incre
ase in tumor necrosis factor-alpha mRNA level in SHR was significantly
greater than that in WKY. Therefore, the increased tumor necrosis fac
tor-alpha mRNA expression may be involved in the increased lipopolysac
charide-induced expression of angiotensinogen gene in fat of SHR at 13
weeks of age. These data suggest that the transcriptional and probabl
y posttranscriptional regulation of angiotensinogen mRNA differs betwe
en SHR and WKY, that the regulation of angiotensinogen gene expression
is tissue-specific, and that the altered expression of the angiotensi
nogen gene may be involved in the development of hypertension.